SKINCATCH Trial: Skin cancer and tumor health care

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON27261

Enrollment

600

Registered

2016-02-05

Start date

2016-02-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

basal cell carcinoma, skin tumors

Interventions

the intervention arm will receive an intensive training in diagnosing and treating skin tumors

Eligibility

Inclusion criteria

Inclusion criteria: Patients with a new non-inflammatory skin tumor

Exclusion criteria

Exclusion criteria: Patients younger than 18 years old, Patients with ASA 3, patients unable to understand the study info and materials without an interpreter.

Design outcomes

Primary

Measure	Time frame
histological completeness of the excision of low risk basal cell carcinoma	—

Secondary

Measure	Time frame
diagnostic accuracy of the diagnosis of the skin tumor cost-effectiveness patient reported outcomes on physician preference, treatment satisfaction and cosmetic outome.	—

Contacts

Public ContactK.H.R Ramdas

Burgemeester Jacobplein 51

skincatch@erasmusmc.nl010 7038953

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)